Answers are grounded in this paper and cite their sources.
This is the first study to demonstrate that fucoidan possesses neuroprotective effects on injured dopaminergic neurons in a LPS-induced animal model of Parkinson's disease. The mechanisms underlying these effects may include its potent down-regulation of intracellular ROS and subsequent proinflammatory cytokine release in LPS-activated microglia.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: